Chris Seper

Chris Seper

MedCity News

Chris Seper runs MedCityNews.com and contributes regularly to the site. He is the vice president of healthcare for Breaking Media, MedCity's corporate owners. Reach him at [email protected]

Follow Chris Seper: Website |


Take a look inside Pfizer’s pretty non-Pfizer innovation room

Take a look inside Pfizer’s pretty non-Pfizer innovation room

March 23, 2015 9:40 am by | 1 Comments

Up on the seventh floor of Pfizer’s cold, black-and-gray exteriored world headquarters in New York is a weird little room with a quirky little poster that will be used (and…


5 years of Obamacare, a new Biogen (hold the Idec), and the great Bob Wachter (Morning Read)

5 years of Obamacare, a new Biogen (hold the Idec), and the great Bob Wachter (Morning Read)

March 23, 2015 6:55 am by | 1 Comments

Stop checking your mainstream media sites, deactivate your “Obamacare” alerts and throw out the front sections of this week’s newspapers: It’s the fifth anniversary of Obamacare and the stories will likely be endless. But there IS something every healthcare innovator should consider contributing to this week.



Epic-CommonWell beef and more on that New York Times cell phone story (Morning Read)

Epic-CommonWell beef and more on that New York Times cell phone story (Morning Read)

March 19, 2015 6:55 am by | 1 Comments

That New York Times cell phone-cancer story was so bad you have to wonder whether The Times will address it today? Also, is there really such a thing as “beef” in healthcare? Because if there is, Epic and the CommonWell Health Alliance have it (and athenhealth and Cerner are getting involved).


A real end to the Doc Fix and a rundown of new cholesterol drugs (Morning Read)

A real end to the Doc Fix and a rundown of new cholesterol drugs (Morning Read)

March 16, 2015 6:55 am by | 0 Comments

Learn about an actual, honest-to-goodness permanent Doc Fix that will hit Congress this week. Check out The New York Times’ full rundown of the new wave of cholesterol drugs from Sanofi and Amgen, and understand better the demand for diagnostics around liver disease in today’s Morning Read.


MedCity News’ investor conference has a new name (MedCity INVEST)

MedCity News’ investor conference has a new name (MedCity INVEST)

March 13, 2015 1:33 am by | 0 Comments

The conversation at the MidAmerica Healthcare Venture Forum earlier this week was all about change: the new business model of healthcare; new investment approaches from venture debt to venture philanthropy;…


AARP backs Rock Health to spread its influence across healthcare’s early stage

AARP backs Rock Health to spread its influence across healthcare’s early stage

March 13, 2015 1:09 am by | 0 Comments

AARP recently partnered up with Rock Health – investing in its second organization focused on nurturing early stage healthcare startups. “It’s all a part of our larger industry-influence strategy” and…


The Apple Watch is here plus an in-depth look at the cancer wars (Morning Read)

The Apple Watch is here plus an in-depth look at the cancer wars (Morning Read)

March 9, 2015 6:55 am by | 0 Comments

The Apple Watch launch is today – and there are enough angles to its launch you may just want to watch many of the live blogs. Also, there was a lot of weekend discussion about big data, the Novartis RNAi selloff and how doctors and hospitals continue to battle over cancer patients.



‘I’d like you to write me a memo.’ Frustration of Obamacare and King v. Burwell in one Supreme Court exchange

‘I’d like you to write me a memo.’ Frustration of Obamacare and King v. Burwell in one Supreme Court exchange

March 5, 2015 2:36 pm by | 2 Comments

So we know Obamacare is way too complicated. We’ve also got lots of hints that the Supreme Court challenge, King v. Burwell, is on shaky ground. But all the frustration…


One week in Chicago with Matter, MedCity News and Forbes

One week in Chicago with Matter, MedCity News and Forbes

March 5, 2015 5:00 am by | 1 Comments (Sponsored)

Things like this don’t happen by accident. Chicago has suddenly become a meeting point for the most important industry in America and a conversation around how the country is reinventing itself through innovation.

You can take part in it all.


More King v. Burwell scenarios and how to really understand Obamacare’s critical moment (Morning Read)

More King v. Burwell scenarios and how to really understand Obamacare’s critical moment (Morning Read)

March 3, 2015 6:55 am by | 0 Comments

The Morning Read provides a 24-hour wrap up of everything else healthcare’s innovators need to know about the business of medicine (and beyond). The author of The Read published it…


It’s King v. Burwell week, the ‘Ebola nurse’ sues and let’s keep docs away from genetics (Morning Read)

It’s King v. Burwell week, the ‘Ebola nurse’ sues and let’s keep docs away from genetics (Morning Read)

March 2, 2015 6:55 am by | 0 Comments

You may not have heard, but the Supreme Court will hear King. v Burwell on Wednesday. We’ll give you s a sampling of the latest prognostications. Plus, get a full read of an in-depth profile of 23andMe founder Ann Wojcicki and news about the “Ebola nurse” suing her hospital.


Big drug M&A looming and we’ll soon know who hacked Anthem (Morning Read)

Big drug M&A looming and we’ll soon know who hacked Anthem (Morning Read)

February 26, 2015 6:55 am by | 0 Comments

The Morning Read provides a 24-hour wrap up of everything else healthcare’s innovators need to know about the business of medicine (and beyond). The author of The Read published it…


Can sweat tests be better than blood tests (thanks to wearable tech)?

Can sweat tests be better than blood tests (thanks to wearable tech)?

February 25, 2015 8:00 am by | 0 Comments

Sweat can be as helpful as blood in checking on health. Doctors already use it for drug tests and insights on diseases like cystic fibrosis. But sweat has its limits…


Will new health-pricing service Guroo.com provide protection in a high-deductible world?

Will new health-pricing service Guroo.com provide protection in a high-deductible world?

February 25, 2015 8:00 am by | 0 Comments

This is a refreshing sentence: We have another entrant in the increasingly crowded health transparency space. The non-profit Health Care Cost Institute today unveiled Guroo.com, which the group says provides…


FDA moves on superbugs, Pfizer’s R&D shrinks and no one is ready if Obamacare crumbles (Morning Read)

FDA moves on superbugs, Pfizer’s R&D shrinks and no one is ready if Obamacare crumbles (Morning Read)

February 25, 2015 6:55 am by | 0 Comments

The Morning Read provides a 24-hour wrap up of everything else healthcare’s innovators need to know about the business of medicine (and beyond). The author of The Read published it…